Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 8;15(3):e35902.
doi: 10.7759/cureus.35902. eCollection 2023 Mar.

Satisfaction With the Use of Subdermal Contraceptive Implant in Women Attending the Specialized Polyclinic Primary Health Care Center in Jeddah City: A Cross-Sectional Study

Razaz Wali  1   2   3 , Abdulkarim M Alghamdi  2   3 , Samer T Ahmed  2   3 , Abdulaziz M Gammash  2   3 , Mohammed M Bukhari  2   3 , Khozam F Alkhozam  2   3 , Mouath H Asiri  2   3
Affiliations

Satisfaction With the Use of Subdermal Contraceptive Implant in Women Attending the Specialized Polyclinic Primary Health Care Center in Jeddah City: A Cross-Sectional Study

Razaz Wali et al. Cureus. .

Abstract

Background Subdermal contraceptive implants are a convenient method of contraception for many women due to the ease of insertion and removal and because they require less follow-up with their health facility. In addition to the contraceptive benefits, women's satisfaction with such devices is essential, as this can affect their quality of life. This study aims to measure women's satisfaction with the subdermal contraceptive implant, Implanon® (Organon & Co., Jersey City, New Jersey, United States), its main side effects, and reasons for removal. Methods A cross-sectional study was conducted on women between the ages of 19 and 65 years who visited the Family Planning Clinic at the Specialized Polyclinic Primary Health Care Center in Jeddah, Saudi Arabia, between January 2018 and December 2021. An online questionnaire was distributed to the women who had Implanon inserted and 84 responded. Demographic and contraceptive data were collected, including the dates of insertion and removal of Implanon and side effects experienced while on Implanon. Results Of the 84 women, 65.84% were satisfied with Implanon, while only 19.04% were unsatisfied with the implant. The most common side effect reported was weight gain (54.76%), followed by menstrual Irregularity. (39.29%). The most common reason for removal was the end of the implant's contraceptive duration (42.86%). Conclusion Most of the women treated at this primary healthcare clinic were satisfied with Implanon. In addition, most of the women removed the implant only due to its reaching the end of its contraceptive duration despite experiencing side effects, and most women said that they would recommend it to their family and friends.

Keywords: contraception; implanon; long-term contraceptive; patient satisfaction; subdermal implant.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Satisfaction of women with the use of Implanon®*
*Organon & Co., Jersey City, New Jersey, United States
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Implanon: a critical review. Le J, Tsourounis C. Ann Pharmacother. 2001;35:329–336. - PubMed
    1. Implanon™ Package Insert. Jersey City, New Jersey: Organon & Co.; [ Oct; 2022 ]. 2006. Organon pharmaceuticals: Implanon [package insert]. U. S Food and Drug Administration website.
    1. Etonogestrel (Implanon), another treatment option for contraception. Maddox DD, Rahman Z. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683610/ PT. 2008;33:337–347.
    1. The contraceptive implant. Hohmann H, Creinin MD. Clin Obstet Gynecol. 2007;50:907–917. - PubMed
    1. Implanon: a new contraceptive implant. Fischer MA. J Obstet Gynecol Neonatal Nurs. 2008;37:361–368. - PubMed

LinkOut - more resources